Comprehensive analysis of ADA2 genetic variants and estimation of carrier frequency driven by a function-based approach H Jee, Z Huang, S Baxter, Y Huang, ML Taylor, LA Henderson, ... Journal of Allergy and Clinical Immunology 149 (1), 379-387, 2022 | 47 | 2022 |
mTORC1 links pathology in experimental models of Still’s disease and macrophage activation syndrome Z Huang, X You, L Chen, Y Du, K Brodeur, H Jee, Q Wang, G Linder, ... Nature communications 13 (1), 6915, 2022 | 23 | 2022 |
Direct capture of neutralized RBD enables rapid point-of-care assessment of SARS-CoV-2 neutralizing antibody titer GG Connelly, OO Kirkland, S Bohannon, DC Lim, RM Wilson, EJ Richards, ... Cell Reports Methods 2 (8), 2022 | 6 | 2022 |
Comparison of disease phenotypes and mechanistic insight on causal variants in patients with DADA2 L Chen, A Mamutova, A Kozlova, E Latysheva, F Evgeny, T Latysheva, ... Journal of Allergy and Clinical Immunology 152 (3), 771-782, 2023 | 4 | 2023 |
Investigating Adenosine Deaminase 2 Activity in Large Vessel Vasculitis A Porter, R Maughan, C Pericleous, A Kiprianos, H Jee, P Lee, ... ARTHRITIS & RHEUMATOLOGY 73, 3903-3905, 2021 | 1 | 2021 |
P295 Establishing adenosine deaminase 2 activity in a cohort of patients with large vessel vasculitis A Porter, R Maughan, C Pericleous, A Kiprianos, H Jee, P Lee, ... Rheumatology 61 (Supplement_1), keac133. 294, 2022 | | 2022 |